Boston Scientific Corp
BSXNYSECIK 885725HealthcareFiscal year ends Dec 31
Reports and events: 396 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2021-08-0616:36 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0000885725-21-000036 |
| 2021-08-0216:31 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0000885725-21-000032 |
| 2021-07-2706:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-21-000028 |
| 2021-06-2416:56 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885725-21-000025 |
| 2021-06-2416:29 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-21-000024 |
| 2021-05-1316:04 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-21-065917 |
| 2021-05-1116:49 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000885725-21-000016 |
| 2021-05-0617:02 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0000885725-21-000014 |
| 2021-04-2806:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-21-000012 |
| 2021-03-2416:19 ET | DEF 14A | Proxy statementPeriod 2021-05-06 | 0001047469-21-000709 |
| 2021-03-1116:41 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000885725-21-000010 |
| 2021-03-0307:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-21-031097 |
| 2021-03-0116:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-21-029993 |
| 2021-02-2316:21 ET | 10-K | Annual reportPeriod 2020-12-31 | 0000885725-21-000008 |
| 2021-02-0306:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-21-000006 |
| 2021-01-2107:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-21-000004 |
| 2021-01-1206:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-21-000002 |
| 2020-12-1416:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-20-000053 |
| 2020-12-0106:37 ET | 8-K | 2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-20-000051 |
| 2020-11-2416:17 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000885725-20-000049 |
| 2020-11-1818:21 ET | 8-K | 2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-20-000046 |
| 2020-11-0506:48 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0000885725-20-000044 |
| 2020-10-2806:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-20-000041 |
| 2020-10-0516:11 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000885725-20-000039 |
| 2020-08-0520:31 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0000885725-20-000036 |
| 2020-08-0320:04 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000885725-20-000034 |
| 2020-07-2910:41 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-20-000031 |
| 2020-06-0820:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000947871-20-000545 |
| 2020-05-2920:54 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000947871-20-000527 |
| 2020-05-2801:54 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0000947871-20-000519 |
| 2020-05-2201:55 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-065010 |
| 2020-05-1821:07 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000947871-20-000487 |
| 2020-05-1500:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-061823 |
| 2020-05-1220:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000885725-20-000024 |
| 2020-05-0621:20 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0000885725-20-000022 |
| 2020-04-2910:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-20-000019 |
| 2020-04-2120:26 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0000947871-20-000397 |
| 2020-04-1013:36 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-045409 |
| 2020-04-0210:40 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885725-20-000017 |
| 2020-03-3010:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-20-000014 |
| 2020-03-2520:30 ET | DEF 14A | Proxy statementPeriod 2020-05-07 | 0001047469-20-001770 |
| 2020-02-2721:52 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0000947871-20-000156 |
| 2020-02-2521:58 ET | 10-K | Annual reportPeriod 2019-12-31 | 0000885725-20-000012 |
| 2020-02-0511:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-20-000009 |
| 2020-02-0511:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-20-000007 |
| 2020-01-1411:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-20-000003 |
| 2019-12-1822:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000947871-19-000976 |
| 2019-12-0522:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0000947871-19-000894 |
| 2019-11-2614:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000947871-19-000866 |
| 2019-11-2021:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000885725-19-000048 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 17:38 ET. Listed shows no prices and gives no investment advice.